SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-026579
Filing Date
2022-11-09
Accepted
2022-11-09 16:00:48
Documents
46
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q govx20220930_10q.htm   iXBRL 10-Q 638048
2 EXHIBIT 31.1 ex_442043.htm EX-31.1 11497
3 EXHIBIT 31.2 ex_442044.htm EX-31.2 11471
4 EXHIBIT 32.1 ex_442045.htm EX-32.1 3605
5 EXHIBIT 32.2 ex_442046.htm EX-32.2 4959
  Complete submission text file 0001437749-22-026579.txt   2827112

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA govx-20220930.xsd EX-101.SCH 31165
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE govx-20220930_cal.xml EX-101.CAL 27041
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20220930_def.xml EX-101.DEF 185317
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20220930_lab.xml EX-101.LAB 176698
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20220930_pre.xml EX-101.PRE 200657
40 EXTRACTED XBRL INSTANCE DOCUMENT govx20220930_10q_htm.xml XML 329155
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39563 | Film No.: 221372413
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences